Table of Contents Author Guidelines Submit a Manuscript
Prostate Cancer
Volume 2011 (2011), Article ID 565230, 10 pages
http://dx.doi.org/10.1155/2011/565230
Research Article

Prostate Cancer Incidence and Mortality in Barbados, West Indies

1Chronic Disease Research Centre, The University of the West Indies, Jemmott's Lane, St. Michael, Barbados
2Department of Preventive Medicine, Stony Brook University Medical Center, Stony Brook, NY 11794-8036, USA
3Ministry of Health, Jemmott's Lane, Bridgetown, Barbados
4Faculty of Medical Sciences, The University of the West Indies, St. Michael, Barbados

Received 20 December 2010; Accepted 27 January 2011

Academic Editor: Cathryn Bock

Copyright © 2011 Anselm J. M. Hennis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. W. Hsing, L. Tsao, and S. S. Devesa, “International trends and patterns of prostate cancer incidence and mortality,” International Journal of Cancer, vol. 85, no. 1, pp. 60–67, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. S. H. Wild, C. M. Fischbacher, A. Brock, C. Griffiths, and R. Bhopal, “Mortality from all cancers and lung, colorectal, breast and prostate cancer by country of birth in England and Wales, 2001–2003,” British Journal of Cancer, vol. 94, no. 7, pp. 1079–1085, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. L. A. G. Ries, M. P. Eisner, C. L. Kosary, and B. F. Hankey, SEER Cancer Statistics Review, 1973–1997, National Cancer Institute, Bethesda, Md, USA, 2000.
  4. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M. J. Thun, “Cancer statistics, 2009,” CA Cancer Journal for Clinicians, vol. 59, no. 4, pp. 225–249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Ferlay, F. Bray, P. Pisani, and D. M. Parkin, GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide, IARC Cancer Base No.5.version 2.0, IARC Press, Lyon, France, 2004.
  6. H. S. Klein, African Slavery in Latin America and the Caribbean, Oxford University Press, Oxford, UK, 1988.
  7. B. Hanchard, G. Blake, C. Wolff et al., “Age-specific incidence of cancer in Kingston and St Andrew, Jamaica, 1993–1997,” West Indian Medical Journal, vol. 50, no. 2, pp. 123–129, 2001. View at Google Scholar · View at Scopus
  8. F. E. Glover Jr., D. S. Coffey, L. L. Douglas et al., “The epidemiology of prostate cancer in Jamaica,” Journal of Urology, vol. 159, no. 6, pp. 1984–1987, 1998. View at Google Scholar · View at Scopus
  9. C. H. Bunker, A. L. Patrick, B. R. Konety et al., “High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago prostate cancer survey,” Cancer Epidemiology Biomarkers and Prevention, vol. 11, no. 8, pp. 726–729, 2002. View at Google Scholar · View at Scopus
  10. T. N. Gibson, G. Blake, B. Hanchard, N. Waugh, and D. McNaughton, “Age-specific incidence of cancer in Kingston and St Andrew Jamaica, 1998–2002,” West Indian Medical Journal, vol. 57, no. 2, pp. 81–89, 2008. View at Google Scholar · View at Scopus
  11. B. Nemesure, S. Y. Wu, I. R. Hambleton, M. C. Leske, and A. J. Hennis, “Risk factors for breast cancer in a black population—the barbados national cancer study,” International Journal of Cancer, vol. 124, no. 1, pp. 174–179, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Benn-Torres, C. Bonilla, C. M. Robbins et al., “Admixture and population stratification in African Caribbean populations,” Annals of Human Genetics, vol. 72, no. 1, pp. 90–98, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Hennis, S. Y. Wu, B. Nemesure, X. Li, and M. C. Leske, “Diabetes in a Carribean population: epidemiological profile and implications,” International Journal of Epidemiology, vol. 31, no. 1, pp. 234–239, 2002. View at Google Scholar · View at Scopus
  14. A. Hennis, S. Y. Wu, B. Nemesure, and M. C. Leske, “Hypertension prevalence, control and survivorship in an Afro-Caribbean population,” Journal of Hypertension, vol. 20, no. 12, pp. 2363–2369, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. C. C. Cowie, K. F. Rust, D. D. Byrd-Holt et al., “Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population. National Health and Nutrition Examination Survey 1999–2002,” Diabetes Care, vol. 29, no. 6, pp. 1263–1268, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. J. A. Cutler, P. D. Sorlie, M. Wolz, T. Thom, L. E. Fields, and E. J. Roccella, “Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988–1994 and 1999–2004,” Hypertension, vol. 52, no. 5, pp. 818–827, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Congdon, J. R. Vingerling, B. E. Klein et al., “Prevalence of cataract and pseudophakia/aphakia among adults in the United States,” Archives of Ophthalmology, vol. 122, no. 4, pp. 487–494, 2004. View at Google Scholar
  18. E. J. Feuer, R. M. Merrill, and B. F. Hankey, “Cancer surveillance series: Interpreting trends in prostate cancer—part II: cause of death misclassification and the recent rise and fall in prostate cancer mortality,” Journal of the National Cancer Institute, vol. 91, no. 12, pp. 1025–1032, 1999. View at Google Scholar · View at Scopus
  19. J. C. Day, “Population projections of the United States by age, sex, race, and Hispanic origin: 1995 to 2050,” US Bureau of the Census, Current Population Reports P25-1130, US Government Printing Office, Washington, DC, USA, 1996. View at Google Scholar
  20. D. M. Parkin, S. Whelan, J. Ferlay, L. Teppo, and D. Thomas, Cancer Incidence in Five Continents, vol. 8, International Agency for Research on Cancer, Lyon, France, 2002.
  21. “Surveillance, Epidemiology, and End Results (SEER) Program. DCCPS,” National Cancer Institute, 2008, www.seer.cancer.gov.
  22. M. P. Fay and E. J. Feuer, “Confidence intervals for directly standardized rates: A method based on the gamma distribution,” Statistics in Medicine, vol. 16, no. 7, pp. 791–801, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. D. M. Parkin, F. I. Bray, and S. S. Devesa, “Cancer burden in the year 2000. The global picture,” European Journal of Cancer, vol. 37, supplement 8, pp. S4–S66, 2003. View at Google Scholar
  24. A. W. Hsing and S. S. Devesa, “Trends and patterns of prostate cancer: what do they suggest?” Epidemiologic Reviews, vol. 23, no. 1, pp. 3–13, 2001. View at Google Scholar · View at Scopus
  25. F. T. Odedina, T. O. Akinremi, F. Chinegwundoh et al., “Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa,” Infectious Agents and Cancer, vol. 4, no. 1, article S2, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. D. M. Parkin, F. Sitas, M. Chirenje, L. Stein, R. Abratt, and H. Wabinga, “Part I: cancer in indigenous Africans-burden, distribution, and trends,” The Lancet Oncology, vol. 9, no. 7, pp. 683–692, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. P. D. Ekwere and S. N. Egbe, “The changing pattern of prostate cancer in Nigerians: current status in the Southeastern States,” Journal of the National Medical Association, vol. 94, no. 7, pp. 619–627, 2002. View at Google Scholar · View at Scopus
  28. D. N. Osegbe, “Prostate cancer in Nigerians: facts and nonfacts,” Journal of Urology, vol. 157, no. 4, pp. 1340–1343, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Ben-Shlomo, S. Evans, F. Ibrahim et al., “The Risk of Prostate Cancer amongst Black Men in the United Kingdom: The PROCESS Cohort Study,” European Urology, vol. 53, no. 1, pp. 99–105, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. F. F. Angwafo, J. Yomi, and A. Mbakop, “Is cancer of the prostate rare in tropical (black) Africa? Case series from The centre hospitalier et universitaire and the hospital general de yaounde from 1986 to 1990,” Bulletin du Cancer/Radiotherapie, vol. 81, no. 2, pp. 155–159, 1994. View at Google Scholar · View at Scopus
  31. D. M. Parkin and C. S. Muir, “Cancer incidence in five continents. Comparability and quality of data,” IARC Scientific Publications, no. 120, pp. 45–173, 1992. View at Google Scholar · View at Scopus
  32. M. Koulibaly, I. S. Kabba, A. Cisse et al., “Cancer incidence in Conakry, Guinea: first results from the Cancer Registry 1992–1995,” International Journal of Cancer, vol. 70, no. 1, pp. 39–45, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Chinegwundoh, M. Enver, A. Lee, V. Nargund, T. Oliver, and Y. Ben-Shlomo, “Risk and presenting features of prostate cancer amongst African-Caribbean, South Asian and European men in North-east London,” British Journal of Urology International, vol. 98, no. 6, pp. 1216–1220, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Dieye, J. Veronique-Baudin, C. Draganescu, and H. Azaloux, “Cancer incidence in Martinique: a model of epidemiological transition,” European Journal of Cancer Prevention, vol. 16, no. 2, pp. 95–101, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Mallick, P. Blanchet, and L. Multigner, “Prostate cancer incidence in Guadeloupe, a French Caribbean archipelago,” European Urology, vol. 47, no. 6, pp. 769–772, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. H. Alvarez, M. E. Yi, L. F. Garrote, and R. C. Rodriguez, “Incidence, mortality and survival from prostate cancer in Cuba, 1977–1999,” European Journal of Cancer Prevention, vol. 13, no. 5, pp. 377–381, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. A. L. Potosky, L. Kessler, G. Gridley, C. C. Brown, and J. W. Horm, “Rise in prostatic cancer incidence associated with increased use of transurethral resection,” Journal of the National Cancer Institute, vol. 82, no. 20, pp. 1624–1628, 1990. View at Google Scholar · View at Scopus
  38. A. L. Potosky, B. A. Miller, P. C. Albertsen, and B. S. Kramer, “The role of increasing detection in the rising incidence of prostate cancer,” Journal of the American Medical Association, vol. 273, no. 7, pp. 548–552, 1995. View at Google Scholar · View at Scopus
  39. R. Etzioni, D. F. Penson, J. M. Legler et al., “Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends,” Journal of the National Cancer Institute, vol. 94, no. 13, pp. 981–990, 2002. View at Google Scholar · View at Scopus
  40. A. Jemal, R. Siegel, E. Ward et al., “Cancer statistics, 2006,” CA: A Cancer Journal for Clinicians, vol. 56, no. 2, pp. 106–130, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. L. X. Clegg, F. P. Li, B. F. Hankey, K. Chu, and B. K. Edwards, “Cancer survival among US whites and minorities: a SEER (surveillance, epidemiology, and end results) program population-based study,” Archives of Internal Medicine, vol. 162, no. 17, pp. 1985–1993, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. P. B. Bach, D. Schrag, O. W. Brawley, A. Galaznik, S. Yakren, and C. B. Begg, “Survival of blacks and whites after a cancer diagnosis,” Journal of the American Medical Association, vol. 287, no. 16, pp. 2106–2113, 2002. View at Google Scholar · View at Scopus
  43. J. O. L. DeLancey, M. J. Thun, A. Jemal, and E. M. Ward, “Recent trends in black-white disparities in cancer mortality,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 11, pp. 2908–2912, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. M. P. Coleman, M. Quaresma, F. Berrino et al., “Cancer survival in five continents: a worldwide population-based study (CONCORD),” The Lancet Oncology, vol. 9, no. 8, pp. 730–756, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Evans, C. Metcalfe, F. Ibrahim, R. Persad, and Y. Ben-Shlomo, “Investigating Black-White differences in prostate cancer prognosis: a systematic review and meta-analysis,” International Journal of Cancer, vol. 123, no. 2, pp. 430–435, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. P. A. Godley, A. P. Schenck, M. A. Amamoo et al., “Racial differences in mortality among medicare recipients after treatment for localized prostate cancer,” Journal of the National Cancer Institute, vol. 95, no. 22, pp. 1702–1710, 2003. View at Google Scholar · View at Scopus
  47. J. D. Albano, E. Ward, A. Jemal et al., “Cancer mortality in the United States by education level and race,” Journal of the National Cancer Institute, vol. 99, no. 18, pp. 1384–1394, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. V. L. Shavers and M. L. Brown, “Racial and ethnic disparities in the receipt of cancer treatment,” Journal of the National Cancer Institute, vol. 94, no. 5, pp. 334–357, 2002. View at Google Scholar · View at Scopus
  49. A. P. Polednak, “Black-white differences in tumor grade (aggresiveness) at diagnosis of prostate cancer, 1992–1998,” Ethnicity and Disease, vol. 12, no. 4, pp. 536–540, 2002. View at Google Scholar · View at Scopus
  50. S. J. Freedland and W. B. Isaacs, “Explaining racial differences in prostate cancer in the United States: sociology or biology?” Prostate, vol. 62, no. 3, pp. 243–252, 2005. View at Publisher · View at Google Scholar · View at Scopus